BrainScope Company, Inc.

BrainScope Company, Inc. is a privately held medical neurotechnology company developing a new generation of handheld, portable, simple-to-use, non-invasive tools to rapidly and objectively assess brain function at the initial point of care. BrainScope’s initial focus is the development of a device for military use, to aid in detection and objective assessment of traumatic brain injury (TBI) / concussion. BrainScope is already working with college athletes to advance the concussion program. In January, BrainScope was one of 16 groups to receive a $300,000 award from General Electric Co . and the NFL to advance the understanding and diagnosis of traumatic brain injuries. BrainScope is working with Purdue University to conduct research with athletes. With these new contracts, the company also plans to work with other universities as well. The goal is to develop a 10-minute assessment capability that could be used on the field after a player has had a head injury. Military contracts have reduced BrainScope 's need for venture capital. The company, which hasn't disclosed the amount of equity it has raised, hasn't closed a major venture round in several years. Its investors include Brain Trust Accelerator Fund , Difference Capital, Maryland Venture Fund, Shaman Ventures, Revolution, created by AOL co-founder Steve Case, and ZG Ventures.